Global Human Organs-on-Chips Supply, Demand and Key Producers, 2023-2029

Global Human Organs-on-Chips Supply, Demand and Key Producers, 2023-2029

The global Human Organs-on-Chips market size is expected to reach $ 563 million by 2029, rising at a market growth of 29.9% CAGR during the forecast period (2023-2029).

Global key players of Human Organs-on-Chips include Emulate, Mimetas, TissUse, Valo Health and CN Bio Innovations. The top five players hold a share over 55%. North America is the largest market, has a share about 42%, followed by Europe, and Asia-Pacific, with share 35% and 18%, separately. In terms of product type, Liver-on-a-chip is the largest segment, occupied for a share of 26%, and in terms of application, Pharmaceutical & Biotechnology Companies has a share about 70%.

An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.

The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).

In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.

This report studies the global Human Organs-on-Chips demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Human Organs-on-Chips, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Organs-on-Chips that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Human Organs-on-Chips total market, 2018-2029, (USD Million)

Global Human Organs-on-Chips total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Human Organs-on-Chips total market, key domestic companies and share, (USD Million)

Global Human Organs-on-Chips revenue by player and market share 2018-2023, (USD Million)

Global Human Organs-on-Chips total market by Type, CAGR, 2018-2029, (USD Million)

Global Human Organs-on-Chips total market by End User, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Human Organs-on-Chips market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Emulate, Mimetas, TissUse, Valo Health, CN Bio Innovations, Hesperos, Draper Laboratory, Nortis and Micronit Microtechnologies B.V., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Organs-on-Chips market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by End User. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Human Organs-on-Chips Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Human Organs-on-Chips Market, Segmentation by Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs

Global Human Organs-on-Chips Market, Segmentation by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others

Companies Profiled:
Emulate
Mimetas
TissUse
Valo Health
CN Bio Innovations
Hesperos
Draper Laboratory
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Altis Biosystems
Bi/ond
Netri
Xona Microfluidics
SynVivo
Beijing Daxiang Biotech

Key Questions Answered

1. How big is the global Human Organs-on-Chips market?

2. What is the demand of the global Human Organs-on-Chips market?

3. What is the year over year growth of the global Human Organs-on-Chips market?

4. What is the total value of the global Human Organs-on-Chips market?

5. Who are the major players in the global Human Organs-on-Chips market?

6. What are the growth factors driving the market demand?